Svedmyr K, Löfdahl C G, Svedmyr N
Allergy. 1984 Jan;39(1):17-22. doi: 10.1111/j.1398-9995.1984.tb01928.x.
Seven asthmatic patients were studied in a single-blind randomized, crossover study after oral administration of 20 mg nifedipine or placebo. Four increasing doses of i.v. terbutaline were then given with 30 min interval. The study was concluded with inhalation of five terbutaline puffs. FEV1 measurements 30 min after intake of nifedipine did not show any difference compared to placebo. During the terbutaline treatment, however, there was a more pronounced bronchodilation after nifedipine than after placebo (P less than 0.05). Terbutaline-induced skeletal muscle tremor was similar after nifedipine and placebo pretreatments. After nifedipine intake there was a decrease of diastolic blood pressure and a reflexogenic tachycardia. Thus, this study showed a small potentiation of the beta 2-adrenoceptor mediated bronchodilation, which is of importance when treating patients with simultaneous asthma and hypertension or angina pectoris.
在7名哮喘患者中进行了一项单盲随机交叉研究,口服20毫克硝苯地平或安慰剂后,每隔30分钟静脉注射4种递增剂量的特布他林,最后吸入5喷特布他林结束研究。硝苯地平摄入30分钟后的第一秒用力呼气量(FEV1)测量结果与安慰剂相比无差异。然而,在特布他林治疗期间,硝苯地平后的支气管扩张比安慰剂后更明显(P<0.05)。硝苯地平和安慰剂预处理后,特布他林引起的骨骼肌震颤相似。摄入硝苯地平后舒张压降低并出现反射性心动过速。因此,本研究显示β2肾上腺素能受体介导的支气管扩张有轻微增强,这在同时患有哮喘和高血压或心绞痛的患者治疗中具有重要意义。